Jack Bendheim Insider Trading Activity
Jack Bendheim has been net-selling over the last 12 months with 0 purchases and 122 sales across 1 company.
PAHC is the most-traded position with 122 trades. The largest single transaction was a sale of PAHC for $2.6M on Feb 10, 2026.
Performance Scorecard
Forward stock performance after each transaction by Jack Bendheim. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +6.3% | 63% | 122 |
| 90 days | — | +6.0% | 53% | 108 |
| 120 days | — | +7.0% | 58% | 90 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersPAHC · PHIBRO ANIMAL HEALTH CORP
🔒 Subscribe to see trade entries
Pro members see exactly when Jack Bendheim bought and sold PAHC.
Upgrade to ProRecent Trades
Showing the 50 most recent of 122 disclosed trades.
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 7, 2026 | PAHC | Sell | 1,350 | $47.59 | $64K | −2.2% | CEO | |
May 7, 2026 | PAHC | Sell | 1,149 | $48.31 | $56K | −1.9% | CEO | |
May 7, 2026 | PAHC | Sell | 2,029 | $49.19 | $100K | −3.5% | CEO | |
May 6, 2026 | PAHC | Sell | 5,634 | $57.18 | $322K | −8.3% | CEO | |
May 6, 2026 | PAHC | Sell | 1,406 | $58.13 | $82K | −2.3% | CEO | |
May 5, 2026 | PAHC | Sell | 776 | $56.37 | $44K | −1.1% | CEO | |
May 5, 2026 | PAHC | Sell | 6,264 | $55.73 | $349K | −8.4% | CEO | |
Apr 30, 2026 | PAHC | Sell | 5,805 | $52.65 | $306K | −7.1% | CEO | |
Apr 30, 2026 | PAHC | Sell | 1,235 | $53.32 | $66K | −1.6% | CEO | |
Apr 29, 2026 | PAHC | Sell | 3,038 | $53.21 | $162K | −3.6% | CEO | |
Apr 29, 2026 | PAHC | Sell | 4,002 | $52.70 | $211K | −4.5% | CEO | |
Apr 28, 2026 | PAHC | Sell | 1,652 | $55.10 | $91K | −1.7% | CEO | |
Apr 28, 2026 | PAHC | Sell | 797 | $56.69 | $45K | −0.9% | CEO | |
Apr 28, 2026 | PAHC | Sell | 4,591 | $56.06 | $257K | −4.9% | CEO | |
Apr 23, 2026 | PAHC | Sell | 421 | $54.56 | $23K | −0.4% | CEO | |
Apr 23, 2026 | PAHC | Sell | 6,619 | $54.07 | $358K | −6.4% | CEO | |
Apr 22, 2026 | PAHC | Sell | 7,040 | $54.29 | $382K | −6.4% | CEO | |
Apr 21, 2026 | PAHC | Sell | 1,625 | $55.35 | $90K | −1.4% | CEO | |
Apr 21, 2026 | PAHC | Sell | 5,415 | $56.17 | $304K | −4.7% | CEO | |
Apr 16, 2026 | PAHC | Sell | 5,190 | $54.56 | $283K | −4.2% | CEO | |
Apr 16, 2026 | PAHC | Sell | 1,850 | $54.88 | $102K | −1.6% | CEO | |
Apr 15, 2026 | PAHC | Sell | 799 | $58.11 | $46K | −3.2% | CEO | |
Apr 15, 2026 | PAHC | Sell | 3,618 | $57.21 | $207K | −12.7% | CEO | |
Apr 15, 2026 | PAHC | Sell | 2,623 | $56.27 | $148K | −8.4% | CEO | |
Apr 14, 2026 | PAHC | Sell | 6,548 | $59.03 | $387K | −17.2% | CEO | |
Apr 14, 2026 | PAHC | Sell | 492 | $59.69 | $29K | −1.6% | CEO | |
Mar 31, 2026 | PAHC | Sell | 6,609 | $53.87 | $356K | −14.6% | CEO | |
Mar 31, 2026 | PAHC | Sell | 431 | $54.35 | $23K | −1.1% | CEO | |
Mar 30, 2026 | PAHC | Sell | 617 | $54.31 | $34K | −1.3% | CEO | |
Mar 30, 2026 | PAHC | Sell | 6,423 | $53.54 | $344K | −12.3% | CEO | |
Mar 26, 2026 | PAHC | Sell | 6,760 | $56.79 | $384K | −11.4% | CEO | |
Mar 26, 2026 | PAHC | Sell | 280 | $57.17 | $16K | −0.5% | CEO | |
Mar 25, 2026 | PAHC | Sell | 1,572 | $55.28 | $87K | −2.4% | CEO | |
Mar 25, 2026 | PAHC | Sell | 552 | $56.86 | $31K | −0.9% | CEO | |
Mar 25, 2026 | PAHC | Sell | 4,916 | $56.00 | $275K | −7.6% | CEO | |
Mar 24, 2026 | PAHC | Sell | 517 | $53.59 | $28K | −0.8% | CEO | |
Mar 24, 2026 | PAHC | Sell | 6,523 | $52.88 | $345K | −8.9% | CEO | |
Mar 19, 2026 | PAHC | Sell | 124 | $53.24 | $7K | −0.2% | CEO | |
Mar 19, 2026 | PAHC | Sell | 4,977 | $52.79 | $263K | −6.3% | CEO | |
Mar 19, 2026 | PAHC | Sell | 1,939 | $51.78 | $100K | −2.4% | CEO | |
Mar 18, 2026 | PAHC | Sell | 3,598 | $53.03 | $191K | −4.2% | CEO | |
Mar 18, 2026 | PAHC | Sell | 4,311 | $51.80 | $223K | −4.7% | CEO | |
Mar 18, 2026 | PAHC | Sell | 2,651 | $53.64 | $142K | −3.2% | CEO | |
Mar 17, 2026 | PAHC | Sell | 5,280 | $51.66 | $273K | −5.5% | CEO | |
Mar 13, 2026 | PAHC | Sell | 5,280 | $48.91 | $258K | −5.2% | CEO | |
Feb 26, 2026 | PAHC | Sell | 711 | $54.28 | $39K | −32.5% | CEO | |
Feb 26, 2026 | PAHC | Sell | 6,329 | $53.67 | $340K | −74.3% | CEO | |
Feb 25, 2026 | PAHC | Sell | 7,040 | $51.71 | $364K | −45.2% | CEO | |
Feb 24, 2026 | PAHC | Sell | 1,151 | $51.88 | $60K | −6.9% | CEO | |
Feb 24, 2026 | PAHC | Sell | 5,889 | $51.27 | $302K | −26.1% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| PAHC | PHIBRO ANIMAL HEALTH CORP | 122 | $32.0M |